CD47 and triple-negative breast carcinoma: Doxorubicin-mediated upregulation of CD47 was also observed in triple negative breast cancer (29) This upregulation of CD47 increases the number of maplirpacept molecules that can bind to the tumor cell, thus increasing its likelihood to be phagocytosed by macrophages.